These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 500738)

  • 21. Incidence of neomycin and framycetin sensitivity.
    Carruthers JA; Cronin E
    Contact Dermatitis; 1976 Oct; 2(5):269-70. PubMed ID: 1017192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and antibacterial activity of amphiphilic lysine-ligated neomycin B conjugates.
    Bera S; Zhanel GG; Schweizer F
    Carbohydr Res; 2011 Apr; 346(5):560-8. PubMed ID: 21353205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPR sensing of small molecules with modified RNA aptamers: detection of neomycin B.
    de-los-Santos-Alvarez N; Lobo-Castañón MJ; Miranda-Ordieres AJ; Tuñón-Blanco P
    Biosens Bioelectron; 2009 Apr; 24(8):2547-53. PubMed ID: 19217276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A self-assembling RNA aptamer-based nanoparticle sensor for fluorometric detection of Neomycin B in milk.
    Ling K; Jiang H; Zhang L; Li Y; Yang L; Qiu C; Li FR
    Anal Bioanal Chem; 2016 May; 408(13):3593-600. PubMed ID: 26942739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new class of branched aminoglycosides: pseudo-pentasaccharide derivatives of neomycin B.
    Fridman M; Belakhov V; Yaron S; Baasov T
    Org Lett; 2003 Oct; 5(20):3575-8. PubMed ID: 14507176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycoside antibiotics. XV Chemical conversion of neomycin B to paromomycin I, 6"'-deamino-6"'-hydroxyneomycin B and 6"'-deamino-6"'-hydroxy-paromomycin I.
    Toda S; Nakagawa S; Naito T; Kawaguchi H
    J Antibiot (Tokyo); 1983 Jan; 36(1):87-91. PubMed ID: 6689595
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapid analysis of native neomycin components on a portable capillary electrophoresis system with potential gradient detection.
    Yuan L; Wei H; Feng H; Li SF
    Anal Bioanal Chem; 2006 Aug; 385(8):1575-9. PubMed ID: 16896633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibacterial activity of guanidinylated neomycin B- and kanamycin A-derived amphiphilic lipid conjugates.
    Bera S; Zhanel GG; Schweizer F
    J Antimicrob Chemother; 2010 Jun; 65(6):1224-7. PubMed ID: 20332193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INTESTINAL ASEPSIS WITH NEOMYCIN AND FRAMYCETIN: A COMPARATIVE STUDY.
    STRATFORD BC; DIXSON S
    Med J Aust; 1964 Jan; 1():74-9. PubMed ID: 14118194
    [No Abstract]   [Full Text] [Related]  

  • 30. CONTACT DERMATITIS FROM NEOMYCIN FRAMYCETIN.
    VICKERS CF
    Lancet; 1965 Jan; 1(7379):273. PubMed ID: 14238084
    [No Abstract]   [Full Text] [Related]  

  • 31. The second international reference preparation of neomycin.
    Lightbown JW; Thomas AH; Grab B; Dixon H
    J Biol Stand; 1979 Jul; 7(3):227-39. PubMed ID: 500737
    [No Abstract]   [Full Text] [Related]  

  • 32. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
    Borkow G; Vijayabaskar V; Lara HH; Kalinkovich A; Lapidot A
    Antiviral Res; 2003 Nov; 60(3):181-92. PubMed ID: 14638394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On cross-sensitization between neomycin, bacitracin, kanamycin and framycetin.
    PIRILA V; ROUHUNKOSKI S
    Dermatologica; 1960 Dec; 121():335-42. PubMed ID: 13735999
    [No Abstract]   [Full Text] [Related]  

  • 34. Collaborative study for the establishment of the 3rd international standard for neomycin.
    Rautmann G; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2013; 2013():93-111. PubMed ID: 24447724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Framycetin sulphate (Soframycin) as a pre-operative bowel-sterilizing agent.
    HORSBURGH AG
    Gut; 1961 Mar; 2(1):51-2. PubMed ID: 13715949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergic contact dermatitis due to neomycin. Cross-sensitivity with other antibiotics; and positive patch tests with the isomeric compounds neomycin B and neomycin C and with neamine.
    KOOIJ R
    S Afr Med J; 1961 May; 35():406-11. PubMed ID: 13753040
    [No Abstract]   [Full Text] [Related]  

  • 37. THE IN VITRO ACTIVITY OF FRAMYCETIN. SPECTRUM, SENSITIVITY TEST AND CROSS RESISTANCE.
    FORCHHAMMER J
    Acta Pathol Microbiol Scand; 1964; 60():549-56. PubMed ID: 14154717
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of the relative amounts of the B and C components of neomycin by ion-exclusion chromatography using refractometric detection.
    Decoster W; Claes P; Vanderhaeghe H
    J Chromatogr; 1981 Jul; 211(2):223-32. PubMed ID: 7251731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ON THE CONFORMATION OF THE ANTIBIOTICS PAROMOMYCIN AND NEOMYCIN B].
    HUETTENRAUCH R
    Pharmazie; 1964 Nov; 19():697-9. PubMed ID: 14346293
    [No Abstract]   [Full Text] [Related]  

  • 40. HYPERSENSITIVITY TO NEOMYCIN.
    FEIWEL M; MUNRO-ASHMAN D
    Br Med J; 1965 Apr; 1(5440):994-5. PubMed ID: 14260640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.